Supramolecular Heterodimer Peptides Assembly for Nanoparticles Functionalization

Archive ouverte

Mathieu, Clélia | Ghosh, Shayamita | Draussin, Julien | Gasser, Adeline | Jacquot, Guillaume | Banerjee, Mainak | Gupta, Tanushree | Schmutz, Marc | Mirjolet, Céline | Tillement, Olivier | Lux, François | Klymchenko, Andrey | Donzeau, Mariel | Pivot, Xavier | Harlepp, Sébastien | Detappe, Alexandre

Edité par CCSD ; Wiley -

International audience. Nanoparticle (NP) surface functionalization with proteins, including monoclonal antibodies (mAbs), mAb fragments, and various peptides, has emerged as a promising strategy to enhance tumor targeting specificity and immune cell interaction. However, these methods often rely on complex chemistry and suffer from batch‐dependent outcomes, primarily due to limited control over the protein orientation and quantity on NP surfaces. To address these challenges, a novel approach based on the supramolecular assembly of two peptides is presented to create a heterotetramer displaying V H Hs on NP surfaces. This approach effectively targets both tumor‐associated antigens (TAAs) and immune cell‐associated antigens. In vitro experiments showcase its versatility, as various NP types are biofunctionalized, including liposomes, PLGA NPs, and ultrasmall silica‐based NPs, and the V H Hs targeting of known TAAs (HER2 for breast cancer, CD38 for multiple myeloma), and an immune cell antigen (NKG2D for natural killer (NK) cells) is evaluated. In in vivo studies using a HER2+ breast cancer mouse model, the approach demonstrates enhanced tumor uptake, retention, and penetration compared to the behavior of nontargeted analogs, affirming its potential for diverse applications.

Suggestions

Du même auteur

Subcutaneous Administration of a Zwitterionic Chitosan‐Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies

Archive ouverte | Gréa, Thomas | CCSD

International audience. Abstract Subcutaneous (SC) administration of monoclonal antibodies (mAbs) is a proven strategy for improving therapeutic outcomes and patient compliance. The current FDA‐/EMA‐approved enzymat...

Anti-BCMA Immuno-NanoPET Radiotracers for Improved Detection of Multiple Myeloma

Archive ouverte | Thomas, Eloise | CCSD

International audience. Current clinical imaging modalities for the sensitive and specific detection of multiple myeloma (MM) rely on nonspecific imaging contrast agents based on gadolinium chelates for magnetic res...

Landscape of Subcutaneous Administration Strategies for Monoclonal Antibodies in Oncology

Archive ouverte | Jacquot, Guillaume | CCSD

International audience. In recent decades, subcutaneous (SC) administration of monoclonal antibodies (mAbs) has emerged as a promising alternative to intravenous delivery in oncology, offering comparable therapeutic...

Chargement des enrichissements...